Establishment Labs (NASDAQ:ESTA) Sets New 12-Month Low - Here's What Happened

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $28.16 and last traded at $29.82, with a volume of 61010 shares changing hands. The stock had previously closed at $28.51.

Analyst Ratings Changes

Separately, Stephens upgraded Establishment Labs to a "strong-buy" rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Establishment Labs presently has a consensus rating of "Buy" and an average price target of $60.60.

Establishment Labs Stock Up 11.4 %

The stock has a market cap of $940.52 million, a P/E ratio of -13.02 and a beta of 1.12. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The business has a 50-day simple moving average of $39.19 and a 200-day simple moving average of $41.69.

Institutional Investors Weigh In On Establishment Labs

A number of large investors have recently added to or reduced their stakes in the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Establishment Labs by 1.8% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock worth $1,525,000 after purchasing an additional 632 shares during the period. R Squared Ltd bought a new stake in shares of Establishment Labs in the fourth quarter valued at approximately $36,000. Federated Hermes Inc. boosted its position in shares of Establishment Labs by 3.0% in the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after acquiring an additional 953 shares during the period. Swiss National Bank boosted its position in shares of Establishment Labs by 2.7% in the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock valued at $1,774,000 after acquiring an additional 1,000 shares during the period. Finally, Verition Fund Management LLC boosted its position in shares of Establishment Labs by 22.8% in the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after acquiring an additional 1,746 shares during the period. Institutional investors own 72.91% of the company's stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.